Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA   US0400471027

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about ARENA PHARMACEUTICALS, INC
04/10 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Complete Registrational ..
04/09 ARENA PHARMACEUTICALS : to Present at the Annual Needham Healthcare Conference
04/07 EISAI : Arena Pharmaceuticals shares rise on weight loss drug patent
04/07 ARENA PHARMACEUTICALS : Receives Additional Patent for BELVIQ® (lorcaserin HCl) ..
03/07 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
03/04 ARENA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
03/02 ARENA PHARMACEUTICALS : reports 4Q loss
03/02 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
02/23 ARENA PHARMACEUTICALS : to Present at the 2015 RBC Capital Markets Healthcare Co..
02/23 ARENA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
02/18 ARENA PHARMACEUTICALS : to Present at the 2015 RBC Capital Markets Healthcare Co..
02/03 ARENA PHARMACEUTICALS : Announces Marketing Approval in South Korea of BELVIQ® (..
02/02 ARENA PHARMACEUTICALS : to Present at the 17th Annual BIO CEO & Investor Confere..
01/21 ARENA PHARMACEUTICALS : Announces Agreement to Sell Common Stock
01/20 ARENA PHARMACEUTICALS : Announces Public Offering of Common Stock
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
04/16 ARENA PHARMACEUTICALS : Receives Additional Patent for BELVIQ® lorcaserin HCl fr..
04/16 ARENA PHARMACEUTICALS : to Present at the Annual Needham Healthcare Conference
04/15 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Complete Registrational ..
04/10 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Complete Registrational ..
04/09 ARENA PHARMACEUTICALS : to Present at the Annual Needham Healthcare Conference
04/07 EISAI : Arena Pharmaceuticals shares rise on weight loss drug patent
04/07 ARENA PHARMACEUTICALS : Receives Additional Patent for BELVIQ® (lorcaserin HCl) ..
03/25 ARENA PHARMACEUTICALS : Patent Issued for Crystalline Forms of ®-8-Chloro-1-Meth..
03/07 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
03/04 ARENA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2014 Financial Re..
More news
Sector news : Biotechnology & Medical Research - NEC
04/17 INCYTE : Emerging Development Pipeline Described in Eleven Abstracts at 2015 AAC..
04/16 QIAGEN NV : N.V. : to Report First Quarter 2015 Results
04/16 Receptos Reports Positive Results for the Maintenance Period of the Phase 2 T..
04/16 QUINTILES TRANSNATIONAL : and Hospital Italiano of Buenos Aires Announce Agreeme..
04/16 ACTELION : to discuss its specialty immunology pipeline compounds
04/16 ACTELION : advances clinical development of its specialty immunology pipeline co..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
04/15 Don't Write Off Arena As Yet
04/13 Vivus Sales Remain Flat - Stock Trend Not Good
04/13 Arena's 15,000 Scripts Set Pace Vs. Competitors
04/13 OREXIGEN : Contrave Scripts Dip - Were My Concerns About Advertising Right?
04/13 Arena Gets Closer On Extended Release Formulation Of Belviq
04/10 SEEKING ALPHA'S BIOTECH WEEKLY : A Biogen Deep Dive, Eisai's Arena Shuffle, And ..


Advertisement
Chart
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF